WS
DARE icon

Wedbush Securities’s Dare Bioscience DARE Stock Holding History

Wedbush Securities’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-133
Closed -$11K – 852
2016
Q4 		$11K Hold
133
– – ﹤0.01% 811
2016
Q3 		$17K Hold
133
– – ﹤0.01% 819
2016
Q2 		$34K Hold
133
– – 0.01% 750
2016
Q1 		$43K Hold
133
– – 0.01% 699
2015
Q4 		$45K Sell
133
-4
-3% -$1.66K 0.01% 685
2015
Q3 		$60K Buy
137
+4
+3% +$2.01K 0.01% 655
2015
Q2 		$73K Buy
+133
New +$91.3K 0.01% 674

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wedbush Securities's DARE Position: Q1 2017 in Review

Wedbush Securities sold out of Dare Bioscience (DARE) in Q1 2017, closing a stake of 133 shares — an estimated $11K sold.

Wedbush Securities first reported a position in DARE in Q2 2015 and held it in 7 quarters. The position peaked at $73K in Q2 2015. 27 funds tracked by Wall St. Rank hold DARE as of Q1 2017.

  • Wedbush Securities reported no remaining Dare Bioscience position as of Q1 2017 after selling out during the quarter.
  • Wedbush Securities sold 133 Dare Bioscience shares in Q1 2017, an estimated $11K.
  • Wedbush Securities first reported a position in Dare Bioscience in Q2 2015 and held it in 7 quarters.
  • Wedbush Securities's Dare Bioscience position peaked at $73K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2017.

Based on Wedbush Securities's 13F filing for Q1 2017, filed 5 May 2017.